Document Detail


Extracorporeal membrane oxygenation in 108 patients with low cardiac output - a single-center experience.
MedLine Citation:
PMID:  21534247     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Background: For short-term ventricular and pulmonary support the extracorporeal membrane oxygenation (ECMO) system using the Bio-Medicus centrifugal pump (Medtronic®, Minneapolis, MN, USA) was applied in 108 patients with cardiac low-output. Methods: From December 1996 to July 2006 the ECMO was implanted in 108 patients (73 adult, mean age: 49.3±18.0 yrs and 35 children, mean age: 1.3 ± 2.7 yrs) with mostly postcardiotomy cardiac low output. The surgical procedures included congenital heart surgery (n=35), heart transplantation (HTx) (n=21), coronary artery bypass operation (CABG) and/or valvular operation (n=33), other operations (n=6) and 13 patients with ECMO support for bridge to recovery. Results: The mean supporting time was 5.1±5.6 days. Overall, 30-day-survival was 40.2%. Best survival rates were seen after congenital heart surgery (24/35, 65.7%) and after HTx (9/21, 42.9%); the worst rates were in the group of CABG and/or valvular operations (5/33, 15.2%), only ECMO support (3/13, 23.1%) and other operations (1/6, 16.7%). Fifty-four patients died while supported by ECMO, 15 were weaned from ECMO but died in hospital, 39 patients were weaned and survived. Causes of death were multi-organ failure (40.6%), bleeding (23.2%), persistent cardiac low output (21.7%), thrombembolic events (8.7%), and graft failure (5.8%). Markers for adverse outcome were identified as older age, high body weight, increased AST/GOT levels, and lower thrombocyte count in adults; and as higher levels of serum creatinine in pediatric patients.?Conclusions: ECMO support showed best results in pediatric patients after congenital heart surgery and in patients after HTx in contrast to multimorbid, older patients with often irreversible myocardial damage.
Authors:
Andres Beiras-Fernandez; Marcus-André Deutsch; Sandra Kainzinger; Ingo Kaczmarek; Ralf Sodian; Peter Ueberfuhr; Bruno Meiser; Michael Schmoeckel; Bruno Reichart; Paolo Brenner
Related Documents :
21273967 - When is the risk acceptable to proceed to noncardiac surgery following an acute myocard...
19803807 - A critical appraisal of experimental factors influencing the definition of the 99th per...
21517727 - Cardiovascular risk in rheumatoid arthritis: when does it really start?
21173497 - Usefulness of computed tomographic pulmonary angiography in the risk stratification of ...
9812077 - Contribution of magnetic resonance imaging in the differential diagnosis of cardiac amy...
16598397 - Transradial unprotected left main coronary stenting supported by percutaneous impella r...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The International journal of artificial organs     Volume:  34     ISSN:  1724-6040     ISO Abbreviation:  Int J Artif Organs     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-05-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7802649     Medline TA:  Int J Artif Organs     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  365-73     Citation Subset:  IM    
Affiliation:
Department of Cardiac Surgery, Grosshadern University Hospital, Ludwig-Maximilians-University (LMU) Munich - Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Continuous blood purification ameliorates RhoA-mediated endothelial permeability in severe acute pan...
Next Document:  Clinical evaluation of the air removal characteristics of an oxygenator with integrated arterial fil...